|Articles|July 27, 2023
DIA 2023: What is the CancerX Initiative?
Jaydev Thakkar, chief operating officer, Biofourmis gives an overview of the CancerX initiative at the 2023 DIA annual meeting in Boston, MA.
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jaydev Thakkar, chief operating officer, Biofourmis, gives an overview of the CancerX initiative and discusses how it was started.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
3
Using AI and Tokenized Data to Match Patients to Protocols
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
